An ever-expanding area of collaboration is occurring among patients, patient organizations, industry, regulators, and governmental organizations to ensure that new drugs developed represent value to the patients they aim to treat, that patient access to innovations is accelerated, and that patient experience and outcomes are optimal.

Integrating the patient experience from the early stages of drug discovery and development through approval and post-marketing is now an accepted norm. However, for many companies, understanding why this is important as well as convincing leadership to invest in these activities can be confusing and elusive. DIA’s Patient Engagement Certificate Program provides the fundamentals about why and how to incorporate patient focus and build organization-wide capabilities.

Register Here